Target- |
MechanismNeurotensin receptors modulators |
|
|
|
|
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismNeurotensin receptors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Argolyn Bioscience, Inc.
0 Patents (Medical) associated with Argolyn Bioscience, Inc.
100 Deals associated with Argolyn Bioscience, Inc.
100 Translational Medicine associated with Argolyn Bioscience, Inc.